SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes

Name: SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes
License: Public Domain

The George Institute

ClinicalTrials.gov · Datasets · License: Public Domain

type 2 diabetes

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 261474
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.